Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 1-2, 2002, Pages 333-340

  Williams, Claire M ^a   Kirkham, Tim C ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Appetite; CB1; CB2; Endocannabinoid; Feeding; Naloxone; Reward; Serotonin; SR141716; SR144528

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANOREXIGENIC AGENT; CANNABINOID 1 RECEPTOR; DEXFENFLURAMINE; DRONABINOL; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; RIMONABANT; SEROTONIN AGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; DRUG RECEPTOR; NARCOTIC ANTAGONIST; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SATIETY; SEROTONINERGIC SYSTEM; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; EATING; METABOLISM; PHYSIOLOGY;

ANIMALS; DEXFENFLURAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; HYPERPHAGIA; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SEROTONIN AGONISTS; TETRAHYDROCANNABINOL;

EID: 0036361973     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00693-1     Document Type: Article

References (57)

1. Cannabis: Effects on hunger and thirst
2. Neurobiology of marijuana abuse
3. The effects of cannabinoids on the brain
4. Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors
5. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
6. The functional neuroanatomy of brain cannabinoid receptors
7. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta-9-tetrahydrocannabinol
8. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
9. Anti-obesity drugs: A critical review of current therapies and future opportunities
10. Appetite suppression and weight loss after the cannabinoid antagonist SR141716
11. Opioid mechanisms in the control of food consumption and taste preferences
12. Delta(9)-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus
13. Perinatal delta(9)-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats
14. Repeated administration of delta(9)-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat
15. SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats
16. Determination and characterisation of a cannabinoid receptor in rat brain
17. Isolation of a brain constituent that binds to the cannabinoid receptor
18. Leptin-regulated endocannabinoids are involved in maintaining food intake
19. Multiple serotonin receptors - Opportunities for new treatments for obesity
20. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters
21. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory
22. Delta(9)-tetrahydrocannabinol-excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
23. 9-tetrahydrocannabinol
24. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
25. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist
26. Cannabinoid interaction with brain reward systems - The neurobiological basis of cannabinoid abuse
27. Cannabinoid transmission and reward-related events
28. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
29. Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat
30. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
31. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
32. Characterisation and localisation of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
33. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716
34. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor
35. Dual action of naloxone revealed by behavioural analysis: Separate effects on initiation and termination of eating
36. Synergistic effects of opioid and cannabinoid antagonists on food intake
37. Endogenous cannabinoids and appetite
38. 9-THC stimulates food intake in Lewis rats: Effects on chow, high-fat and sweet high-fat diets
39. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
40. Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain
41. Pharmacological and biochemical interactions between opioids and cannabinoids
42. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
43. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
44. Molecular characterisation of a peripheral receptor for cannabinoids
45. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors
46. Functional interaction between opioid and cannabinoid receptors in drug self-administration
47. Recent clinical experience with dronabinol
48. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
49. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
50. SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset
51. The dopamine hypothesis of reward: Past and current status
52. 1 opioid receptor mechanism
53. Facilitory effect of Δ-9-tetrahydrocannabinol on hypothalamically induced feeding
54. Anandamide induces overeating: Mediation by central cannabinoid receptors
55. Hyperphagia induced by intra-accumbens injection of 2-arachidonoyl glycerol
56. 9-THC